| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 04/04/2002 | US20020039579 Immunoglobulin antibodies |
| 04/04/2002 | US20020039577 Methods for regulating a lymphocyte-mediated immune response by blocking costimulatory signals and blocking LFA-1 mediated adhesion in lymphocytes |
| 04/04/2002 | DE10045380A1 Verfahren zur Kontrazeption und dessen Darreichungsform Method of contraception and its dosage form |
| 04/04/2002 | CA2425749A1 Otic microbial combinations for treatment of animals with ruptured tympanic membrane |
| 04/04/2002 | CA2424038A1 Coated medical devices |
| 04/04/2002 | CA2424021A1 Catecholamine compositions and uses thereof |
| 04/04/2002 | CA2423978A1 Potassium salt of thiazolidinedione and its use as antidiabetic |
| 04/04/2002 | CA2423955A1 Kini-3 motor protein and methods for its use |
| 04/04/2002 | CA2423953A1 Hydrolases |
| 04/04/2002 | CA2423889A1 Methods and compositions for screening modulators of lipid kinases |
| 04/04/2002 | CA2423701A1 Oxidoreductases |
| 04/04/2002 | CA2423694A1 Transferases |
| 04/04/2002 | CA2423668A1 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 04/04/2002 | CA2423613A1 Transgenic drosophilia melanogaster expressing beta amyloid |
| 04/04/2002 | CA2423487A1 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 04/04/2002 | CA2423449A1 Tricyclic antidepressants and their analogues as long-acting local anesthetics and analgesics |
| 04/04/2002 | CA2423446A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/04/2002 | CA2423424A1 Secreted proteins |
| 04/04/2002 | CA2423413A1 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas |
| 04/04/2002 | CA2423313A1 Methods of treating inflammatory and immune reactions and compositions therefor |
| 04/04/2002 | CA2423141A1 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 04/04/2002 | CA2422530A1 Human drug metabolizing enzymes |
| 04/04/2002 | CA2420960A1 Potassium channel interactors and uses therefor |
| 04/03/2002 | EP1192957A2 Coating for medical devices |
| 04/03/2002 | EP1192952A2 Combination, for treating depression and anxiety, containing an NK-3 receptor antagonist and a CNS penetrant NK-1 receptor antagonist |
| 04/03/2002 | EP1192951A2 Pharmaceutical composition containing a compound having angiotensin II antagonistic activity in combination with another compound |
| 04/03/2002 | EP1192947A1 Pharmaceutical composition comprising trehalose for ophthalmic use |
| 04/03/2002 | EP1192945A2 Use of an estrogen agonist/antagonist for treating osteoarthritis |
| 04/03/2002 | EP1192943A2 Use of growth hormone secretagogues in conjunction with physical exercise |
| 04/03/2002 | EP1192939A2 Methods for reduction of inflammation and erythema |
| 04/03/2002 | EP1192462A1 Prevention and treatment of amyloid-associated disorders |
| 04/03/2002 | EP1192281A2 Use of ras inhibitors for inhibiting muscle atrophy |
| 04/03/2002 | EP1192279A2 Diagnostics and therapeutics for cardiovascular disorders |
| 04/03/2002 | EP1192277A2 Diagnostics and therapeutics for restenosis |
| 04/03/2002 | EP1192275A2 Prediction of risk of interstitial lung disease |
| 04/03/2002 | EP1192268A2 Nucleic acid binding of multi-zinc finger transcription factors |
| 04/03/2002 | EP1192259A1 Tankyrase2 materials and methods |
| 04/03/2002 | EP1192258A2 Human poly(adp-ribose) polymerase 2 materials and methods |
| 04/03/2002 | EP1192257A2 Human regulators of intracellular phosphorylation |
| 04/03/2002 | EP1192251A1 Human sel-10 polypeptides and polynucleotides that encode them |
| 04/03/2002 | EP1192250A2 Human rna metabolism proteins (rmep) |
| 04/03/2002 | EP1192249A1 47 human secreted proteins |
| 04/03/2002 | EP1192247A1 Sphingosine kinase enzyme |
| 04/03/2002 | EP1192243A1 Method for enhancing hematopoiesis |
| 04/03/2002 | EP1192187A1 Heparin compositions that inhibit clot associated coagulation factors |
| 04/03/2002 | EP1192185A2 Apo-2L RECEPTOR AGONIST AND CPT-11 SYNERGISM |
| 04/03/2002 | EP1192174A2 Antagonists of bmp and tgf beta signalling pathways |
| 04/03/2002 | EP1192128A1 Thiol derivative, metallo-beta-lactamase inhibitors |
| 04/03/2002 | EP1191975A2 Improvement of t cell mediated immunity |
| 04/03/2002 | EP1191948A2 High dose radionuclide complexes for bone marrow suppression |
| 04/03/2002 | EP1191945A1 Methods and compositions for control of bone formation via modulation of leptin activity |
| 04/03/2002 | EP1191943A1 Novel anti-allergic agents |
| 04/03/2002 | EP1191942A2 Treatment of endometriosis with antileukoprotease |
| 04/03/2002 | EP1191940A1 Tumor necrosis factor receptor 5 |
| 04/03/2002 | EP1191933A1 Nasal delivery of apomorphine |
| 04/03/2002 | EP1191928A1 Methods involving changing the constitutive and stimulated secretions of the local reproductive system of women |
| 04/03/2002 | EP1191924A1 Pharmaceutical dosage form for pulsatile delivery of (d-threo)-methylphenidate and a second cns stimulant |
| 04/03/2002 | EP1191845A1 Prevention of brain damage in stroke |
| 04/03/2002 | EP1009393B1 Transdermal therapeutic system comprising a reservoir-type pressure-sensitive adhesive layer and a back layer with uni-directional resilience |
| 04/03/2002 | EP0918507B1 Aerosol formulations |
| 04/03/2002 | EP0856051B1 Novel 3' terminal sequence of hepatitis c virus genome and diagnostic and therapeutic uses thereof |
| 04/03/2002 | EP0754049B1 Anti-fungal methods and materials |
| 04/03/2002 | EP0736002B1 Compound capable of introducing at least one molecule into a cell |
| 04/03/2002 | CN1343205A Dimeric compounds and as inhibitors of neuraminidase |
| 04/03/2002 | CN1343127A Potentiation of anti-CD38-immunotoxin cytotoxicity |
| 04/03/2002 | CN1343118A Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes |
| 04/03/2002 | CN1342452A Foaming emulsion for treating fatty skin |
| 04/02/2002 | US6365715 Human cardiac/brain tolloid-like protein |
| 04/02/2002 | US6365714 Amino acid sequence of a polypeptide; antiinflammatory agents; antiproliferative agents; antiapoptotic agents |
| 04/02/2002 | US6365627 Method for treating a patient with neoplasia by treatment with a paclitaxel derivative |
| 04/02/2002 | US6365623 Treatment of acne using lipoic acid |
| 04/02/2002 | US6365619 Cyclic oligopeptide vcam-1 inhibitor; (s)-.beta.-(3-methoxypropyl) ((4-((2-methylphenylaminocarbonylamino)-phenyl) acetyl)amino)acetyl-amino-3,4-dimethoxy-benzenepropanoic acid |
| 04/02/2002 | US6365577 Administering to the subject, in a suitable pharmaceutical carrier, a pharmaceutically effective amount of an antisense agent which is morpholino oligonucleotide for inhibiting expression of p53 |
| 04/02/2002 | US6365572 For therapy of diseases related to increased or unwanted synthesis of basement membranes such as diabetes mellitus; atherosclerosis; cancer; diabetic retinopathia; fibroplasia retrolentalis; or psoriasis, rheumatoic arthritis |
| 04/02/2002 | US6365402 Growth differentiation factor-9 |
| 04/02/2002 | US6365391 Isolated human serine protease, nucleic acid molecules encoding human serine protease, and uses thereof |
| 04/02/2002 | US6365389 Human protein kinase H2LAU20 |
| 04/02/2002 | US6365371 Amino acid sequence; diagnosis, prevention and treatment of cancer, reproductive disorders, immune disorders, and developmental disorders; anticarcinogenic agents |
| 04/02/2002 | US6365370 Dna which codes for 5-hydroxytryptamine 3-c protein of defined amino acid sequence; antiinflammatory agents; treatment of huntington's disease, alzheimer's disease and others |
| 04/02/2002 | US6365365 Method of determining whether an agent modulates glycosyl sulfotransferase-3 |
| 04/02/2002 | US6365359 Identifying prp pharmacore by determining functional residues of protein involved in complex interactions, developing three dimensional structures, comparing them with other compounds and identifying compounds consistent with binding to protein |
| 04/02/2002 | US6365358 Polypeptide of defined amino acid sequence; diagnosis, prevention and treatment of cancer, developmental, autoimmune and nervous system disorders; anticarcinogenic agents; antiinflammatory agents |
| 04/02/2002 | US6365190 Preparing aqueous solution of hydrophilic component and organic solution of hydrophobic component, delivering solutions to atomizer separately, atomizing together to produce droplets containing both components, spray drying |
| 04/02/2002 | US6365184 Multiple unit tableted dosage forms containing acid susceptible proton pump inhibitor in combination with one or more nsaids and wherein at least proton pump inhibitor is protected by enteric coated layer |
| 04/02/2002 | US6365180 Oral liquid compositions |
| 04/02/2002 | US6365164 Injecting therapeutic amount of botulinum toxin into prostate gland of patient, thereby alleviating symptoms of prostatic hyperplasia, benign prostatic hyperplasia or prostatic enlargement |
| 04/02/2002 | US6365156 Contacting mucosal membrane of animal with chimeric molecule comprising viral-specific ligand and bacterial-specific ligand which is specific for bacteria colonizing membrane |
| 04/02/2002 | US6365145 Using liposome; applying light |
| 04/02/2002 | US6365135 Bleaching human skin, hair |
| 04/02/2002 | CA2357961A1 Method for reduction of inflammation and erythema |
| 04/02/2002 | CA2357929A1 Nmda nr2b antagonists for the treatment of depression |
| 04/02/2002 | CA2357925A1 Prophylactic use of n-methyl-d-asparate (nmda) antagonists |
| 04/02/2002 | CA2144047C Method and compositions for maintaining glomerular filtration rate while inhibiting extracellular matrix accumulation |
| 03/28/2002 | WO2002025285A1 Prognostic indicator |
| 03/28/2002 | WO2002024924A2 Protein phosphatases |
| 03/28/2002 | WO2002024920A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 03/28/2002 | WO2002024912A2 Isolated nucleic acid molecules which encode a soluble il-tif/il-22 receptor or binding protein which binds to il-tif/il-22, and uses thereof |
| 03/28/2002 | WO2002024910A2 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof |
| 03/28/2002 | WO2002024906A1 Induction of exon skipping in eukaryotic cells |
| 03/28/2002 | WO2002024892A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding them, and uses thereof |